StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a research report report published on Sunday morning. The firm issued a buy rating on the stock.
Mannatech Stock Performance
NASDAQ MTEX opened at $7.14 on Friday. The company has a quick ratio of 0.56, a current ratio of 1.08 and a debt-to-equity ratio of 0.09. Mannatech has a twelve month low of $6.75 and a twelve month high of $15.10. The stock has a 50-day moving average of $7.42 and a 200 day moving average of $8.20.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its earnings results on Tuesday, May 14th. The company reported $0.63 earnings per share (EPS) for the quarter. Mannatech had a negative return on equity of 15.37% and a negative net margin of 1.31%. The firm had revenue of $29.39 million for the quarter.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
See Also
- Five stocks we like better than Mannatech
- 3 Monster Growth Stocks to Buy Now
- ScottsMiracle-Gro Stock Blooms After Investor Day Optimism
- How to Use the MarketBeat Excel Dividend Calculator
- Leading Beverage Company’s Stock Bubbles Higher: Rally Ahead
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Can This Meme Stock Stage One Last Rally?
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.